skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Thoughts on the public bickering between mr glassman and mr boland? With the large decline in cbl since it's ipo, is it something you would invest in?

Thanks

Robert
Read Answer Asked by Robert on October 05, 2015
Q: With these choppy markets, what do you think of Corbys as a place to wait it out. Also, do you think the dividend at 7.6% is sustainable?
GUY
Read Answer Asked by Guy R. on October 05, 2015
Q: Hello, is it worth keeping inter pipeline after the decline or better to get out
thanks
Read Answer Asked by margit on October 05, 2015
Q: could you please give me a read on veresen.I have this one in my non registered account and am considering selling before a possible dividend cut.the pay out percentage seems very high.
Thank you
Read Answer Asked by Allen on October 05, 2015
Q: Your opinion of Oracle please, and would you buy this company at this price.
Matter of fact would you be buying any U.S. stocks with our dollar being so low.
Thanks
Read Answer Asked by Gordon on October 05, 2015
Q: Hi Peter, please comment on Pure, its back to 2013 levels and has had a rough week. We're looking to enter it if you still like it and can't see any news on the decline except for market weakness. Thank you, Paul
Read Answer Asked by Paul on October 05, 2015
Q: I know that in the context of the broader market being horrendous that many equities are down. But pur has been putting in new lows and insider selling is very high. My instinct is to take a loss and move on yet you still hold this in your growth portfolio. How has your confidence level on this one changed in the last month?
Read Answer Asked by Harry on October 05, 2015
Q: Do you think it is wise to reduce exposure to National bank given the recent news? Thank you.
Read Answer Asked by Linda on October 05, 2015
Q: I follow the balanced equity portfolio. I would like to understand when you make the changes indicated for the month's theoretical portfolio, and when that information is available on the Website.

For example, the July portfolio indicates the following changes: "July 2 shares of CSU and bought 30 shares of BIN, sold FM". When where they done in July, and when is the information available to 5i members?

Thanks,
IF
Read Answer Asked by ishay on October 05, 2015
Q: It's my expectation BXE will be announcing some asset sales in the near future to help lower their debt. Generally speaking, do you think this will bump the share price up a bit? Thanks.
Read Answer Asked by Curtis on October 05, 2015
Q: HI Folks: I know you like Goldcorp. What are your second and third favourite gold miners and would you consider a gold royalty company (other than Franco N) at this time?
Read Answer Asked by Ed on October 05, 2015
Q: Hello Peter & Co,
10% of my portfolio is in that sector
CRH,CXR,GUD,PHM,PLI,RX and VRX
With the intent to shifting funds from what I perceive to be lower ranked to higher ranked ones, I would appreciate your input.
Thanks,
Antoine
Read Answer Asked by Antoine on October 05, 2015
Q: Hello Team
I am thinking of purchasing a gold stock etf.XGD was the one i was thinking of.Are there gold etf's you may consider better.One to two year hold.Thank You
Read Answer Asked by glenn on October 05, 2015
Q: This has been very lonely stand up stock in my portfolio. Rather unusual for it to be as it trades thinly at points. Now I can see a reason for it in it's recent purchase of Healthmark. I can't recall when the last time was that it bought something. Do you think this might represent a change in corporate thinking? What does the purchase mean to your thinking on RPI and how significant do you think it is for the company?
I am looking to sell some shares. Hopefully at higher prices?
Read Answer Asked by Gerald on October 05, 2015
Q: Hi- just thought my fellow subscribers who own Valeant might be interested in this article, which, in brief, states that Valeant is one of the greatest increasers of drug prices and may be affected by the Hilary Clinton furor.
http://www.zerohedge.com/news/2015-10-04/more-pain-biotechs-ahead-valeants-astronomical-price-increases-take-center-stage-pfi
Read Answer Asked by Pat on October 05, 2015
Q: Wondering what your thoughts are on stonegate. At 0.03 could it be considered a good gamble?
Read Answer Asked by Lois on October 05, 2015
Q: I believe you've suggested around a 25% allocation to your growth portfolio while also suggesting 20 stocks overall for diversification. With that said would you say selecting 15 stocks from the balanced equity portfolio and 5 stocks from the growth portfolio would be a sound strategy for a young investor that doesn't need the income from the income portfolio? This is assuming diversification across sectors. A etf like VXC or XAW would be added for international exposure. Cheers
Read Answer Asked by Josh on October 05, 2015
Q: I have been looking at this company for some time. It seems awfully cheap, and is growing nicely. Mr. Glassman appears to have lots of expertise in the area. I realize there are far to many stocks for 5i to research, but my question is if this is a stock that you would ever consider covering, or are there some fundamental underlying issues that would exclude it from your consideration (similar to your reluctance to recommend resource stocks?) Are there any major issues that give you pause? What do you see as the main risks with this company?

As always, thank you for your help.
Read Answer Asked by Donald on October 05, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!